26-A-18085-ACC EFFICACY AND SAFETY OF OLEZARSEN FOR THE MANAGEMENT OF DYSLIPIDEMIA: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLEDTRIALS
JACC · 2026-04 · 87 (13) · A254
DOI: 10.1016/j.jacc.2026.02.627 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift JACC, 2026-04. Verfasst von Muhammad Burhan und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Burhan, M., Naveed, M. A., Ibrahim, T., Ashraf, S., Fatima, K., Ali, A., Chigurupati, H. D., Sandhyavenu, H., Qureshi, B., & Neppala, S. (2026). 26-A-18085-ACC EFFICACY AND SAFETY OF OLEZARSEN FOR THE MANAGEMENT OF DYSLIPIDEMIA: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLEDTRIALS. JACC, 87(13), A254. https://doi.org/10.1016/j.jacc.2026.02.627
Vancouver
Burhan M, Naveed MA, Ibrahim T, Ashraf S, Fatima K, Ali A, et al. 26-A-18085-ACC EFFICACY AND SAFETY OF OLEZARSEN FOR THE MANAGEMENT OF DYSLIPIDEMIA: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLEDTRIALS. JACC. 2026;87(13):A254. doi:10.1016/j.jacc.2026.02.627
BibTeX
@article{Burhan2026,
author = {Burhan, Muhammad and Naveed, Muhammad Abdullah and Ibrahim, Taha and Ashraf, Saad and Fatima, Kisa and Ali, Ahila and Chigurupati, Himaja Dutt and Sandhyavenu, Harigopal and Qureshi, Binish and Neppala, Sivaram},
title = {26-A-18085-ACC EFFICACY AND SAFETY OF OLEZARSEN FOR THE MANAGEMENT OF DYSLIPIDEMIA: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLEDTRIALS},
journal = {JACC},
year = {2026},
volume = {87},
number = {13},
pages = {A254},
doi = {10.1016/j.jacc.2026.02.627}
}
EUVIMED